A Randomized, Phase III Clinical Trial of Low‐Dose Tamoxifen for Selected Patients with Molecular Low-risk Early‐Stage Breast Cancer
Read more about this trial →← Back to available clinical trials
A Randomized, Phase III Clinical Trial of Low‐Dose Tamoxifen for Selected Patients with Molecular Low-risk Early‐Stage Breast Cancer
Read more about this trial →